MUNICH, GERMANY / ACCESSWIRE / October 25, 2023 / The 29th annual BIO-Europe, the premier partnering conference for the global biopharmaceutical industry, is set to take place November 6-8, 2023, in the vibrant city of Munich, Germany.
Partnering is in full swing with meeting requests having shown an impressive 65% increase compared to last year, while scheduled meetings have surged by a remarkable 93%. On top of one-to-one meetings, the event will cater to the needs of the entire value chain with world-class workshops and panels, innovative company presentations, active exhibition and a variety of networking opportunities making this event an unrivalled forum for companies across the biotech value chain to meet and do business.
The opening keynote plenary discussion "Global trends and next wave of Biopharma innovation" on Monday, November 6, will feature speakers Isma Hachi, Director at IQVIA and Alexendra Zemp, Partner at McKinsey & Company.
One of the highlights on Tuesday will be the Startup Spotlight at BIO-Europe, sponsored by Bayer, a lively competition offering selected startup companies to make a 4-minute pitch and participate in a live feedback session from judges including J.P Kruse, Lead of Co.Lab Berlin at Bayer Pharmaceuticals, Jörg Knaebelein, Scientific Finder Collaborate to Cure Hub EMEA at Bayer Pharmaceuticals, Carolin Clement, Head of Unit Biotech and Pharma, Berlin Partner for Business and Technology and Christoph Broja, Managing Director at EQT Life Sciences, who will evaluate the pitches and select a first and second place winner.
On Wednesday, we are also excited to feature a new "Media round-up" session that will bring together a comprehensive recap of BIO-Europe 2023 and capture the pulse of the event by diving into the highlights, fresh perspectives, key insights, and impactful takeaways shared by renowned trade journalists.
Additionally, high-level executives from pharma, biotech, and the investment sector are confirmed to participate in panels and fireside chats covering a wide range of topics - AI, pharma to venture capital, pharma pipelines, the latest trends in obesity, cell & gene, and oncology, regional case studies and close up collaborations on the open stage within the exhibit hall.
BIO-Europe is produced by EBD Group, the leading partnering firm for the global biotechnology industry, with the support of the Biotechnology Innovation Organization (BIO).
For more information, please visit the conference website at: https://informaconnect.com/bioeurope
Follow BIO-Europe 2023 on X (formerly Twitter) @EBDGroup (hashtag: BIOEurope) or on LinkedIn.
About EBD Group
EBD Group's overriding mission is to help collaborations get started across the life science value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE®, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings. Today our events (BIO-Europe®, BIO-Europe Spring®, BioPharm America, Biotech Showcase, ChinaBio® Partnering Forum, and BioEquity Europe) annually attract more than 15,000 senior life science executives who engage in over 50,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry. EBD Group is an Informa company. For more information, please visit www.ebdgroup.com.
Media Contacts:
MC Services AG
+49 89 2102280
contact@mc-services.eu
Karina Marocco
EBD Group
kmarocco@ebdgroup.com
SOURCE: EBD Group
View source version on accesswire.com:https://www.accesswire.com/796238/ebd-group-the-global-biopharma-community-is-now-actively-partnering-for-bio-europer-2023
